Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

Vetoquinol stock

VETO.PA
FR0004186856
A0LEWB

Price

79.40
Today +/-
-0.50
Today %
-0.63 %
P

Vetoquinol stock price

%
Weekly
Details

Price

Overview

The Quote Chart provides detailed and dynamic insights into the Vetoquinol stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Vetoquinol stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Vetoquinol stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Vetoquinol's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Vetoquinol Stock Price History

DateVetoquinol Price
11/1/202479.40 undefined
10/31/202479.90 undefined
10/30/202480.60 undefined
10/29/202480.20 undefined
10/28/202482.70 undefined
10/25/202481.70 undefined
10/24/202481.30 undefined
10/23/202482.50 undefined
10/22/202483.10 undefined
10/21/202482.20 undefined
10/18/202483.10 undefined
10/17/202486.00 undefined
10/16/202486.00 undefined
10/15/202486.40 undefined
10/14/202486.00 undefined
10/11/202486.40 undefined
10/10/202486.40 undefined
10/9/202487.20 undefined
10/8/202485.70 undefined
10/7/202484.60 undefined

Vetoquinol Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Gain insights into Vetoquinol, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Vetoquinol from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Vetoquinol’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Vetoquinol. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Vetoquinol’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Vetoquinol’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Vetoquinol’s growth potential.

Vetoquinol Revenue, EBIT and net profit per share

DateVetoquinol RevenueVetoquinol EBITVetoquinol Net Income
2026e607.92 M undefined88.67 M undefined62.03 M undefined
2025e585.72 M undefined81.84 M undefined57.11 M undefined
2024e557.46 M undefined74.56 M undefined51.41 M undefined
2023529.27 M undefined77.75 M undefined55.56 M undefined
2022539.78 M undefined84.23 M undefined48 M undefined
2021521.27 M undefined87.11 M undefined62.86 M undefined
2020427.47 M undefined56.05 M undefined19.22 M undefined
2019395.99 M undefined46.06 M undefined28.59 M undefined
2018367.94 M undefined48.32 M undefined36.26 M undefined
2017352.17 M undefined45.71 M undefined34.83 M undefined
2016350.35 M undefined42.12 M undefined27.83 M undefined
2015342.61 M undefined38.83 M undefined24.16 M undefined
2014315.3 M undefined35.28 M undefined25.77 M undefined
2013299.7 M undefined33.9 M undefined23.6 M undefined
2012298.3 M undefined31.4 M undefined22.6 M undefined
2011284.1 M undefined31.8 M undefined22.7 M undefined
2010282 M undefined32.2 M undefined22.3 M undefined
2009252.2 M undefined28.7 M undefined18.2 M undefined
2008234.4 M undefined27.6 M undefined18.6 M undefined
2007233.4 M undefined29.2 M undefined18.6 M undefined
2006211.6 M undefined25.7 M undefined15.8 M undefined
2005196.6 M undefined18.8 M undefined12.4 M undefined
2004181.5 M undefined16.9 M undefined10 M undefined

Vetoquinol Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)EBIT (M)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)DIV. ()DIV. GROWTH (%)SHARES (M)DOCUMENTS
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024e2025e2026e
190181196211233234252282284298299315342350352367395427521539529557585607
--4.748.297.6510.430.437.6911.900.714.930.345.358.572.340.574.267.638.1022.013.45-1.865.295.033.76
43.6854.1455.6148.3448.5045.3044.0543.6242.2556.3858.1959.3759.0659.4361.3661.3160.0060.8961.8061.9761.25---
8398109102113106111123120168174187202208216225237260322334324000
211618252927283231313335384245484656878477748188
11.058.849.1811.8512.4511.5411.1111.3510.9210.4011.0411.1111.1112.0012.7813.0811.6513.1116.7015.5814.5613.2913.8514.50
101012151818182222222325242734362819624755515762
--20.0025.0020.00--22.22--4.558.70-4.0012.5025.935.88-22.22-32.14226.32-24.1917.02-7.2711.768.77
------------------------
------------------------
11.311.311.311.112.512.411.811.911.811.911.911.8611.8611.8511.8611.8411.8311.8311.8311.8311.83000
------------------------
Details

Keystats

Revenue and Growth

The Vetoquinol Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Vetoquinol is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
200320042005200620072008200920102011201220132014201520162017201820192020202120222023
                                         
9.113.72721.740.325.848.155.857.881.683.990.8187.07103.3113.02117.6384.51129.446993.71147.46
45.645.74741.442.347.146.251.352.35056.562.9458.8964.1757.1860.7376.172.7577.5374.6289.32
4.82.62.68.75.31111.89.610.811.58.59.0911.6111.1415.8914.1414.9215.59.1216.215.89
32.53234.736.439.3434048.953.455.356.470.8468.3769.4369.3877.1677.3585.53111.59116.09103.54
01.71.40001.92.92.23.23.73.212.443.153.74.454.433.956.457.997.17
9295.7112.7108.2127.2126.9148168.5176.5201.6209236.88228.39251.18259.18274.1257.32307.16273.69308.61363.39
37.740.440.84444.142.641.641.944.146.844.350.2850.7552.6554.6256.1870.7472.2772.9984.6589.7
0.60.30.40.30.40.40.40.60.60.60.70.70.741.162.131.882.011.992.071.441.49
000000000000000000000
20.120.322.129.32626.429.741.236.333.832.947.3847.2646.5442.5142.8842.95174.99178.52168.71154
19.118.319.926.225.433.658.345.151.865.958.776.377.3678.6975.8780.7129.4479.8683.4676.1775.04
023.82.65.26.55.612.297.86.17.837.988.959.669.859.019.8113.8312.268.62
77.581.387102.4101.1109.5135.6141141.8154.9142.7182.48184.09187.99184.79191.48254.15338.93350.87343.24328.84
169.5177199.7210.6228.3236.4283.6309.5318.3356.5351.7419.36412.48439.17443.97465.58511.47646.09624.56651.85692.23
                                         
4144.844.960.860.860.860.860.870.870.870.829.7129.7129.7129.7129.7170.8370.8370.8370.8370.83
0000000000041.1341.1341.1341.1341.1300000
24.526.641.950.46776.294.1123.4140.4156.7176.3198.3217.85240.34270.45299.72321.91335.95393.15431.54477.73
0000000000.5-11.2-0.780.765.25-5.62-7.46-6.39-35.03-22.72-17.8-21.55
000000000000000000000
65.571.486.8111.2127.8137154.9184.2211.2228235.9268.34289.44316.42335.66363.1386.35371.75441.26484.57527.01
18.81722.820.723.851.423.627.323.726.325.730.6324.8926.6924.8425.6530.4541.4746.9439.0442
10.914.31515.618.3019.222.822.522.42325.1726.7928.427.4728.7530.6436.5843.9737.5637.98
11.310.315.813.813.94.816.419.321.318.618.924.3818.9422.4624.7823.2526.1144.957.5555.9251.45
008.76.544.64.710.94.717.6154.640.030.030.030.050.930.110.890.121.26
8.916.47.55.82.71.922.422.910.610.911.214.38.878.828.786.424.58116.57.437.746.71
49.95869.862.462.762.786.3103.282.895.893.899.1279.5286.3985.8984.1492.71239.55156.77140.39139.39
49.836.834.830.232.730.234.814.116.321.910.838.1724.1615.436.630.26.588.257.079.569.66
25.54.52.71.11.22.12.22.13.43.65.1310.4510.836.957.377.788.438.328.027.17
2.35.33.94.13.95.25.65.75.87.37.68.558.8510.058.7710.818.4318.0311.069.228.9
54.147.643.23737.736.642.52224.232.62251.8543.4636.3122.3518.3632.7834.7126.4426.825.73
104105.611399.4100.499.3128.8125.2107128.4115.8150.97122.98122.7108.24102.5125.49274.26183.21167.19165.12
169.5177199.8210.6228.2236.3283.7309.4318.2356.4351.7419.31412.42439.11443.9465.6511.84646.01624.47651.76692.14
Details

Balance Sheet

Understanding the Balance Sheet

The balance sheet of Vetoquinol provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Vetoquinol's financial health and stability.

Assets

Vetoquinol's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Vetoquinol must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Vetoquinol after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Vetoquinol's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
20032004200520062007200820092010201120122013201420152016201720182019202020212022
109121518181822222223252427343628196247
886810101112121212131715121224463142
00000000000000000000
-103-53-133-8-14-8-16-9-15-12-14-23-139-29-52
0175566897812121181213172425
02211111000000000000
024103776106911139151214122631
1720302337214034293428413843413752928962
-10-8-12-29-8-8-7-7-9-9-7-11-13-13-13-14-14-145-32-22
-10-7-9-29-8-26-35-7-21-24-7-52-15-13-15-17-64-145-33-21
01300-17-270-11-150-41-10-1-3-500-10
00000000000000000000
-22-3-6-7-2-522-21-45-1029-19-8-8-8-8111-114-6
190015-1000900000000000
-5-4-82-6-917-2511-1427-23-13-14-15-20101-120-16
-------1.00-1.00---------5.00-5.00--
-2-1-1-5-2-3-3-3-3-3-4-4-4-4-5-5-5-4-5-9
1812-321-1522181041701694-3345-6125
7.2912.5617.65-6.3228.7813.0332.3826.620.3725.1220.5730.125.3829.6127.5223.6737.69-53.2357.3140.36
00000000000000000000

Vetoquinol stock margins

The Vetoquinol margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Vetoquinol. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Vetoquinol.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Vetoquinol's sales revenue. A higher gross margin percentage indicates that the Vetoquinol retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Vetoquinol's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Vetoquinol's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Vetoquinol's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Vetoquinol. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Vetoquinol's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Vetoquinol Margin History

Vetoquinol Gross marginVetoquinol Profit marginVetoquinol EBIT marginVetoquinol Profit margin
2026e61.27 %14.59 %10.2 %
2025e61.27 %13.97 %9.75 %
2024e61.27 %13.38 %9.22 %
202361.27 %14.69 %10.5 %
202261.94 %15.61 %8.89 %
202161.94 %16.71 %12.06 %
202060.89 %13.11 %4.5 %
201959.9 %11.63 %7.22 %
201861.18 %13.13 %9.85 %
201761.42 %12.98 %9.89 %
201659.37 %12.02 %7.94 %
201559.11 %11.33 %7.05 %
201459.37 %11.19 %8.17 %
201358.12 %11.31 %7.87 %
201256.35 %10.53 %7.58 %
201142.34 %11.19 %7.99 %
201043.69 %11.42 %7.91 %
200944.09 %11.38 %7.22 %
200845.61 %11.77 %7.94 %
200748.5 %12.51 %7.97 %
200648.44 %12.15 %7.47 %
200555.65 %9.56 %6.31 %
200454.27 %9.31 %5.51 %

Vetoquinol Stock Sales Revenue, EBIT, Earnings per Share

The Vetoquinol earnings per share therefore indicates how much revenue Vetoquinol has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue Vetoquinol earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Vetoquinol's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Vetoquinol’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Vetoquinol's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Vetoquinol Revenue, EBIT and net profit per share

DateVetoquinol Sales per ShareVetoquinol EBIT per shareVetoquinol Earnings per Share
2026e51.38 undefined0 undefined5.24 undefined
2025e49.5 undefined0 undefined4.83 undefined
2024e47.12 undefined0 undefined4.35 undefined
202344.73 undefined6.57 undefined4.7 undefined
202245.62 undefined7.12 undefined4.06 undefined
202144.07 undefined7.37 undefined5.31 undefined
202036.15 undefined4.74 undefined1.63 undefined
201933.47 undefined3.89 undefined2.42 undefined
201831.07 undefined4.08 undefined3.06 undefined
201729.7 undefined3.86 undefined2.94 undefined
201629.55 undefined3.55 undefined2.35 undefined
201528.88 undefined3.27 undefined2.04 undefined
201426.58 undefined2.97 undefined2.17 undefined
201325.18 undefined2.85 undefined1.98 undefined
201225.07 undefined2.64 undefined1.9 undefined
201124.08 undefined2.69 undefined1.92 undefined
201023.7 undefined2.71 undefined1.87 undefined
200921.37 undefined2.43 undefined1.54 undefined
200818.9 undefined2.23 undefined1.5 undefined
200718.67 undefined2.34 undefined1.49 undefined
200619.06 undefined2.32 undefined1.42 undefined
200517.4 undefined1.66 undefined1.1 undefined
200416.06 undefined1.5 undefined0.88 undefined

Vetoquinol business model

Vetoquinol SA is a French company specializing in animal health products and is one of the leading organizations in this field worldwide. It was founded in 1933 and is headquartered in Lure, France. Vetoquinol is one of the most popular companies on Eulerpool.com.

Vetoquinol SWOT Analysis

Strengths

  • Vetoquinol SA is a leading global player in the animal health market, with a strong presence in both developed and emerging markets.
  • The company has a diverse portfolio of high-quality products for both companion and production animals.
  • Vetoquinol SA has a long-standing history in the industry, with over 80 years of experience, which has earned it a strong reputation.
  • The company has a well-established marketing and distribution network, ensuring a wide reach and accessibility of its products.

Weaknesses

  • Vetoquinol SA's dependency on a few key products for a significant portion of its revenue poses a risk in case of product failures or fluctuations in demand.
  • The company's focus on international markets exposes it to regulatory and political risks in different countries.
  • Vetoquinol SA may face challenges in keeping up with rapidly changing technologies and innovations in the animal health industry.

Opportunities

  • The growing global demand for animal protein and increased pet ownership presents opportunities for Vetoquinol SA to expand its customer base and product offerings.
  • Emerging markets, such as Asia and Latin America, offer untapped potential for Vetoquinol SA to enter and establish a stronger presence.
  • Strategic partnerships and collaborations with research institutions or other industry players can enhance Vetoquinol SA's research and development capabilities.

Threats

  • Intense competition from other global animal health companies may put pressure on Vetoquinol SA's market share and pricing strategies.
  • Economic downturns or recessionary periods can impact consumer spending on animal health products, affecting Vetoquinol SA's revenue.
  • Regulatory changes related to animal welfare, antibiotic use, or environmental concerns may require Vetoquinol SA to adapt its products and practices.

Vetoquinol Eulerpool Fair Value

Details

Fair Value

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Vetoquinol historical P/E ratio, EBIT multiple, and P/S ratio

Vetoquinol shares outstanding

The number of shares was Vetoquinol in 2023 — This indicates how many shares 11.833 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

Revenue Per Share

Revenue per share represents the total revenue Vetoquinol earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Vetoquinol's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Vetoquinol’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Vetoquinol's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Vetoquinol dividend history and estimates

In 2023, Vetoquinol paid a dividend amounting to 0.8 EUR. Dividend means that Vetoquinol distributes a portion of its profits to its owners.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

Dividend Overview

The dividend per year chart for Vetoquinol provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Vetoquinol’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Vetoquinol's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Vetoquinol Dividend History

DateVetoquinol Dividend
2026e0.87 undefined
2025e0.87 undefined
2024e0.87 undefined
20230.8 undefined
20220.8 undefined
20210.5 undefined
20200.38 undefined
20190.48 undefined
20180.46 undefined
20170.43 undefined
20160.41 undefined
20150.39 undefined
20140.37 undefined
20130.35 undefined
20120.33 undefined
20110.3 undefined
20100.29 undefined
20090.27 undefined
20080.27 undefined
20070.23 undefined

Vetoquinol dividend payout ratio

In 2023, Vetoquinol had a payout ratio of 17.5%. The payout ratio indicates the percentage of the company's profits that Vetoquinol distributes as dividends.
  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

What is Yearly Payout Ratio?

The yearly payout ratio for Vetoquinol represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Vetoquinol could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Vetoquinol's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Vetoquinol Payout Ratio History

DateVetoquinol Payout ratio
2026e16.88 %
2025e17.59 %
2024e15.54 %
202317.5 %
202219.72 %
20219.41 %
202023.38 %
201919.87 %
201815.02 %
201714.64 %
201617.47 %
201519.16 %
201417.04 %
201317.68 %
201217.28 %
201115.54 %
201015.51 %
200917.53 %
200818 %
200715.44 %
200617.5 %
200517.5 %
200417.5 %

The World’s Best Investors Are On Eulerpool

Unfortunately, there are currently no price targets and forecasts available for Vetoquinol.

Vetoquinol shareholders

%
Name
Stocks
Change
Date
67.31653 % Étienne Frechin Family7,964,61308/16/2024
3.56104 % Fidelity Management & Research Company LLC421,32808/31/2024
2.78687 % Oddo BHF Asset Management S.A.S329,731-8,0428/31/2024
2.34993 % Invesco Advisers, Inc.278,03408/31/2024
1.04419 % BNP Paribas Asset Management UK Limited123,5443,2889/30/2024
0.94304 % The Vanguard Group, Inc.111,5772,0979/30/2024
0.79809 % Danske Bank Asset Management94,4271,1649/30/2024
0.51281 % Janus Henderson Investors60,67409/30/2024
0.50123 % Montanaro Asset Management Limited59,303-1,6778/31/2024
0.46486 % Mandatum Asset Management Ltd55,00055,0005/31/2023
1
2
3
4
5
...
8

Vetoquinol Executives and Management Board

Mr. Matthieu Frechin(53)
Vetoquinol Chief Executive Officer, Director (since 2001)
Compensation 287,631
Mr. Etienne Frechin(84)
Vetoquinol Chairman of the Board (since 1962)
Compensation 195,683
Mr. Alain Masson(60)
Vetoquinol Deputy Chief Executive Officer and Head Pharmacist, Group Quality Director
Compensation 158,043
Ms. Marie-Josephe Baud(73)
Vetoquinol Independent Director
Compensation 22,000
Mr. Louis Champel(78)
Vetoquinol Independent Director
Compensation 22,000
1
2

Vetoquinol Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
SupplierCustomer0,900,490,220,10-0,52-0,52
SupplierCustomer0,830,630,800,440,17-0,33
1

Most common questions regarding Vetoquinol

What values and corporate philosophy does Vetoquinol represent?

Vetoquinol SA represents values of innovation, expertise, and commitment to animal health. With a strong corporate philosophy focused on the well-being and care of animals, Vetoquinol SA strives to develop and provide effective veterinary medicines and services. This leading animal health company aims to improve the quality of life for pets, livestock, and other animals worldwide. With its extensive research and development efforts, Vetoquinol SA consistently introduces innovative solutions, ensuring the highest standards of animal health. With a passion for animals, Vetoquinol SA remains dedicated to nurturing the bond between humans and their beloved pets through science-based veterinary care.

In which countries and regions is Vetoquinol primarily present?

Vetoquinol SA is primarily present in various countries and regions worldwide. It has a prominent presence in Europe, particularly in France where its headquarters are based. Apart from its significant market presence in France, the company extends its operations across other European countries, such as Germany, Italy, Spain, and the United Kingdom. In addition, Vetoquinol SA has established a strong presence in the Americas, including the United States, Mexico, and Brazil. The company is also active in Asia, with operations in China, India, and Japan, among others. Furthermore, Vetoquinol SA serves the veterinary market in Africa and Oceania.

What significant milestones has the company Vetoquinol achieved?

Some significant milestones achieved by Vetoquinol SA include: 1. Expansion of Global Presence: Vetoquinol SA has successfully expanded its presence in several global markets, strengthening its position as a leading international animal health company. 2. Strategic Acquisitions: The company has made strategic acquisitions that have broadened its product portfolio and allowed for diversified growth opportunities. These acquisitions have further solidified Vetoquinol SA's position in the animal health industry. 3. Innovative Product Development: Vetoquinol SA has continuously focused on research and development, leading to the introduction of innovative animal health products. This commitment to innovation has helped the company provide effective solutions for veterinarians and pet owners alike. 4. Sustainable Initiatives: Vetoquinol SA has shown a strong commitment to sustainability, implementing various initiatives to reduce its environmental footprint and support responsible practices within the industry. It is important to note that while the company name may appear frequently in the answer to ensure SEO optimization, the content should prioritize providing accurate and relevant information about Vetoquinol SA's milestones.

What is the history and background of the company Vetoquinol?

Vetoquinol SA is a leading global animal health company, specializing in providing a wide range of veterinary pharmaceutical products and solutions. Founded in 1933 by Doctor Pierre-Richard Dick, Vetoquinol has a rich history and a strong commitment to animal health. With its headquarters in France, the company has expanded its operations globally, serving customers in over 100 countries. Vetoquinol focuses on developing innovative and high-quality products for both companion animals and livestock. With a dedicated team of experts and a customer-centric approach, Vetoquinol continuously strives to improve animal well-being and contribute to the advancement of veterinary medicine.

Who are the main competitors of Vetoquinol in the market?

The main competitors of Vetoquinol SA in the market include industry players such as Zoetis Inc., Elanco Animal Health Inc., and Merck Animal Health. These companies also operate in the animal health sector and offer a range of pharmaceutical and veterinary products, similar to Vetoquinol SA. Vetoquinol SA faces competition from these companies in terms of product offerings, market share, and innovation. However, Vetoquinol SA has established a strong presence in the market with its high-quality veterinary medicines and solutions, maintaining a competitive edge in the industry.

In which industries is Vetoquinol primarily active?

Vetoquinol SA is primarily active in the animal health industry.

What is the business model of Vetoquinol?

Vetoquinol SA, a renowned company in the veterinary pharmaceutical industry, follows a comprehensive business model. The company primarily focuses on the development, manufacturing, and distribution of veterinary medicines and products. Through its wide range of high-quality medications, vaccines, and supplements, Vetoquinol aims to improve animal health and well-being. By collaborating with veterinarians and pet owners worldwide, the company provides solutions for both production animals and pets. With a strong commitment to research and development, Vetoquinol constantly innovates its product portfolio to address evolving veterinary needs. This business model enables Vetoquinol SA to contribute significantly towards animal healthcare, upholding its position as a leader in the industry.

What is the P/E ratio of Vetoquinol 2024?

The Vetoquinol P/E ratio is 18.27.

What is the P/S ratio of Vetoquinol 2024?

The Vetoquinol P/S ratio is 1.69.

What is the Quality Investing of Vetoquinol?

The Quality Investing for Vetoquinol is 8/10.

What is the revenue of Vetoquinol 2024?

The expected Vetoquinol revenue is 557.46 M EUR.

How high is the profit of Vetoquinol 2024?

The expected Vetoquinol profit is 51.41 M EUR.

What is the business model of Vetoquinol

Vetoquinol SA is a leading global company in the animal health industry, offering a wide range of products and services for pets, livestock, and other animals. The company is headquartered in France and operates in over 100 countries worldwide. Vetoquinol SA's divisions include four main areas: 1. Pharmaceuticals: Vetoquinol SA has a wide range of pharmaceuticals for pets, livestock, and other animals. The pharmaceutical products are divided into categories such as antibiotics, antifungals, anti-inflammatory agents, parasiticides, anthelmintics, nutrients, and other medications. 2. Nutritional supplements: Vetoquinol SA offers a wide range of nutritional supplements for pets, livestock, and other animals. These products have been specifically developed to provide optimal nutrition to animals and improve their health and well-being. 3. Vaccines: Vetoquinol SA produces vaccines for pets, livestock, and other animals. The vaccines protect animals from infectious diseases and improve overall health. 4. Services: Vetoquinol SA provides a wide range of services for veterinarians and animal owners. These include training, technical support, consulting, and other value-added services. Vetoquinol SA's business model focuses on improving the health and well-being of animals through innovative products and services. The company aims to offer high-quality products and services at a fair price and adopts a holistic approach to animal health. Some of the key products from Vetoquinol SA are the antibiotics Vetrimoxin® (Amoxicillin) and Enrofloxacin, as well as the antifungals Amphotericin B, Ketoconazole, and Fluconazole. The company also produces a wide range of nutritional supplements such as Joint Force™, Calopet™, and Bio-Cat™. Furthermore, Vetoquinol SA manufactures vaccines such as Leucogen®, Leucoguard®, and Equilis®. Vetoquinol SA strives to understand the needs of its customers and offer innovative products and services tailored to the needs of animals and their owners. The company has a wide network of distribution partners worldwide to ensure that its products and services are available to veterinarians and animal owners. Overall, Vetoquinol SA's business model is focused on improving the health and well-being of animals. The company aims to provide high-quality products and services and support its customers through training, consulting, and technical support.

What is the Vetoquinol dividend?

Vetoquinol pays a dividend of 0.8 EUR distributed over payouts per year.

How often does Vetoquinol pay dividends?

The dividend cannot currently be calculated for Vetoquinol or the company does not pay out a dividend.

What is the Vetoquinol ISIN?

The ISIN of Vetoquinol is FR0004186856.

What is the Vetoquinol WKN?

The WKN of Vetoquinol is A0LEWB.

What is the Vetoquinol ticker?

The ticker of Vetoquinol is VETO.PA.

How much dividend does Vetoquinol pay?

Over the past 12 months, Vetoquinol paid a dividend of 0.8 EUR . This corresponds to a dividend yield of about 1.01 %. For the coming 12 months, Vetoquinol is expected to pay a dividend of 0.87 EUR.

What is the dividend yield of Vetoquinol?

The current dividend yield of Vetoquinol is 1.01 %.

When does Vetoquinol pay dividends?

Vetoquinol pays a quarterly dividend. This is distributed in the months of July, July, July, July.

How secure is the dividend of Vetoquinol?

Vetoquinol paid dividends every year for the past 20 years.

What is the dividend of Vetoquinol?

For the upcoming 12 months, dividends amounting to 0.87 EUR are expected. This corresponds to a dividend yield of 1.09 %.

In which sector is Vetoquinol located?

Vetoquinol is assigned to the 'Health' sector.

Wann musste ich die Aktien von Vetoquinol kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Vetoquinol from 6/6/2024 amounting to 0.85 EUR, you needed to have the stock in your portfolio before the ex-date on 6/4/2024.

When did Vetoquinol pay the last dividend?

The last dividend was paid out on 6/6/2024.

What was the dividend of Vetoquinol in the year 2023?

In the year 2023, Vetoquinol distributed 0.8 EUR as dividends.

In which currency does Vetoquinol pay out the dividend?

The dividends of Vetoquinol are distributed in EUR.

All fundamentals about Vetoquinol

Our stock analysis for Vetoquinol Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Vetoquinol Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.